Stay updated on AK104 Bispecific Antibody Clinical Trial

Sign up to get notified when there's something new on the AK104 Bispecific Antibody Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 Bispecific Antibody Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study record's history now shows that recruitment is closed to participants and a new revision (v3.6.0) was posted, replacing the prior revision (v3.5.5).
    Difference
    0.4%
    Check dated 2026-06-12T16:24:42.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.5.5 was added to the study's history, and the previous revision label v3.5.4 was removed from the list of changes.
    Difference
    0.1%
    Check dated 2026-06-05T12:11:01.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.5.4 was added to the study record history, replacing the previous v3.5.3. This reflects an administrative update to the record's documentation.
    Difference
    0.1%
    Check dated 2026-05-14T22:53:28.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.3) is added to the Study Record Versions, replacing the previous v3.5.2, indicating an updated page revision.
    Difference
    0.1%
    Check dated 2026-04-30T16:10:33.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added a new revision entry v3.5.2 to the record history. Removed revision v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T09:30:11.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Revision history updated to include v3.5.0 and remove v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T19:43:05.000Z thumbnail image

Stay in the know with updates to AK104 Bispecific Antibody Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 Bispecific Antibody Clinical Trial page.